New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 12, 2012
07:42 EDTUSPH, DXCM, INSM, IART, PBTH, AHS, CPHD, BIOS, ARNA, CLDXOppenheimer to host a conference
23rd Annual Healthcare Conference is being held in New York on December 12-13 with webcasted presentations to begin on December 12 at 7:45 am; not all company presentations may be webcasted. Webcast Link
Sign up for a free trial to see the rest of the stories you've been missing.
October 5, 2015
18:56 EDTARNAOn The Fly: After Hours Movers
HIGHER: Regulus Therapeutics (RGLS), up 8.7% after the company announced that it will present new preclinical data on RG-012 for kidney disease... Palatin Technologies (PTN), up 9.6% after director Robert deVeer Jr. buys 10,000 shares of common stock... Arena Pharmaceuticals (ARNA), up 4.7% after CEO Jack Lief announced his retirement and Harry Hixson was named interim CEO... DuPont (DD), up 5.9% after CEO and chair Ellen Kullman retires... Ruckus Wireless (RKUS), up 4.9% after joining the S&P 600... Starz (STRZA), up 10.1% after the LA Times reports that Lionsgate (LGF) is in advanced talks to merge with Starz. DOWN AFTER EARNINGS: Container Store (TCS), down 10.4%. ALSO LOWER: Sarepta Therapeutics (SRPT), down 3.8% after filing to sell $125M of common stock... Haemonetics (HAE), down 12.2% after lowering its fiscal 2016 outlook... Energy XXI (EXXI), down 8.3% after filing a $500M mixed securities shelf... Mallinckrodt (MNK), down 1.6% after announcing that it will provide a business update and financial guidance for the fiscal year ending September 30, 2016, on an investor call on October 6.
16:20 EDTARNAArena Pharmaceuticals CEO Jack Lief retires, Harry Hixson named interim CEO
Subscribe for More Information
October 1, 2015
11:22 EDTUSPHU.S. Physical Therapy management to meet with Jefferies
Meeting to be held in Boston on October 7 hosted by Jefferies.
07:31 EDTCLDXLeerink to hold a roundtable
Subscribe for More Information
06:09 EDTIARTOsiris assumed with a Hold from Buy at Brean Capital
Brean Capital analyst Jason Wittes downgraded Osiris Therapeutics (OSIR) to Hold after assuming coverage of the name. The analyst views the stock as fairly valued at current levels and sees increased competition from Integra LifeSciences' (IART) entry into the diabetic foot ulcer market.
September 30, 2015
11:48 EDTIARTFTC requires divestitures as condition of Wright Medical, Tornier merger
Wright Medical Group (WMGI) and Tornier (TRNX) have agreed to sell Tornier's U.S. rights and assets related to its total ankle replacements and total silastic toe joint replacements to resolve Federal Trade Commission charges that the proposed $3.3B merger would illegally reduce competition for these devices, the FTC announced. Under the proposed settlement, Wright and Tornier will divest the rights and assets to these devices to Integra Lifesciences (IART) and provide Integra with intellectual property, manufacturing technology, and existing inventory, as well as other assets and assistance to ensure that Integra can effectively compete in the markets. The proposed order also requires Wright and Tornier to supply Integra with total ankle replacements for up to three years and total silastic toe joint replacements for up to a year, while Integra transitions to become an independent competitor in these markets.
September 23, 2015
15:14 EDTBIOSGabelli lowers stake in BioScrip to 16.39% from 17.5%
Subscribe for More Information
13:47 EDTINSMInsmed withdraws CF indication from EMA application for amikacin
Subscribe for More Information
08:59 EDTUSPHU.S. Physical Therapy management to meet with Barrington
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use